We speculated that CK7, ELF3, EGFR and EphB4 expression in PMBCs are appropriate markers for detecting CTCs and have potential in the evaluation of prognosis and monitoring of therapy in NSCLC. This evidence concerns the gene KRT7 and non-small cell lung carcinoma.